Category Archives: HIVMA

What we’re reading: Four decades of HIV have wrought remarkable change, continuing loss, remaining challenges

By on .

The Science Speaks editorial staff (me) took some time off to attend to some long overdue family business in Michigan, thanks to an uptick in vaccine uptake and access there, a place now emerging from a recent discouraging surge of transmissions. Enjoying the benefits the remarkable accomplishments of science and public health have given us offered […]

First long-acting injectable treatment for HIV represents an exciting step forward, should be optimized with equity, investment

By on .

First long-acting injectable treatment for HIV represents an exciting step forward, should be optimized with equity, investment Dr. Rajesh Gandhi is the Co-Director of the Harvard Center for AIDS Research and the site leader of the MGH Clinical Research Site in the Harvard/Miriam AIDS Clinical Trials Unit and a scientific member of the Department of […]

IDWeek: A talk examines micro-epidemics, and the elusive solutions they require

By on .

At a conference dominated by discussion of a coronavirus pandemic that, circling the globe, has led to the infections of more than 41 million people and killed more than a million, Dr. Judith Feinberg this week came to talk about a smaller scale public health challenge in a talk titled “HIV Micro-Epidemics: When HIV Comes […]

IDWeek 2020: A look at HIV, COVID-19 in America highlights the role of racism as a vector of infectious diseases

By on .

The 2020 Edward H. Kass Lecture: “All policy is health policy” When the disparate and damaging impacts of HIV and AIDS on Black Americans across the United States finally began to draw notice in the late 1980s and early ’90s, the recognition came with an assumption. Those most affected by the epidemic, common wisdom had […]